BC-PP is also more unfavorable, as the rate of HER-2 positive and Ki-67≥20% was significantly higher than that of its controls (P=0.01, 0.018, respectively), although age, year of diagnosis, and TNM stage were well matched. This evidence concerns the gene ERBB2 and breast cancer.